Acarix AB (publ)

kr 0.17As of Sun 8 Nov 2026, 12:00 UTC
STO:ACARIXHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (35.59%)
Div yield —
ROE (98.24%)
Medical Devices
Beta (5Y) (0.29)
PE TTM —
TSR TTM (40.50%)
Mkt cap kr 205.9M
ROIC (60.71%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 0.20
20.56%
(38.87%)
Hold 11|4|12|9|0
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
—
—
—
—
1.83%
(4.85%)
2.76%
5.36%
Revenuekr M
9.400
9.746
9.556
9.672
10.69%
10.30%
2.18%
6.13%
Peers (US$20.82M)
Cap (US$)
PE
25.86M
—
21.76M
—
Capital
TTM
5Y
10Y
Leveragex
2.608
0.288
0.237
EBIT/Intx
1.275
3.226
2.545
Own earn%
146.76
(34.40)
(14.57)
Sh yield%
23.81
33.39
35.22
Owners
Insiders/Inst%
3.59
31.02
Short interest%
0.57
SBC / revenue%
2.86
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
21–24
$1 testx
—
Incr. ROIC%
13